전립선암, 신장 결석, 요실금 등 비뇨기과 문제는 더욱 더 흔해지고 있습니다. 이러한 질병이 만연하는 것에 따라 보다 우수한 진단·수술 기술에 대한 요구가 증가하며, 2024년에는 394억 7,000만 달러를 넘어 2031년에는 573억 9,000만 달러에 달합니다.
또한 저침습적 치료와 로봇 보조 기술의 도입은 수술 정확도 향상, 치료 시간 단축, 환자 치료 결과 개선으로 시장 확대를 촉진하고 있습니다. 이미징 및 장비 재료의 개선과 같은 기술적 혁신은 보다 효과적이고 덜 침습적인 대체 치료법을 제공함으로써 시장을 발전시킬 것이며, 2024-2031년 약 4.79%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
비뇨기과 수술기기 시장 정의/개요
비뇨기과 수술 기기는 요로 및 남성 생식기관을 포함한 비뇨기과 질환의 진단, 치료 및 관리에 사용되는 특수 기기 및 장비입니다. 이러한 기기에는 최소침습 수술용 기구, 로봇 보조 시스템, 영상 진단 장비 등이 포함됩니다. 비뇨기과 수술 장비는 신장 결석, 전립선암, 요실금, 방광 질환 등 다양한 질환을 치료하는 데 사용됩니다. 이러한 장비는 최소 침습 수술과 기존 접근법을 보다 현실화하여 환자의 예후를 개선하고 회복 시간을 단축할 수 있도록 돕습니다. 비뇨기과 수술 기기의 미래는 로봇 수술, 향상된 영상 기술, 더 나은 진단 및 치료를 위한 스마트 기기 등의 기술 발전으로 인해 유망한 것으로 보입니다. 지속적인 기술 혁신은 정확도를 높이고 침습성을 낮추며 환자의 편안함을 향상시켜 복잡한 비뇨기과 질환의 치료에서 이러한 장비의 적용 범위와 효과를 넓히고 있습니다.
노인 인구 증가는 비뇨기과 수술 기기 시장의 성장을 가속할 가능성이 높습니다. 전 세계 인구의 고령화와 함께 전립선 비대증(BPH), 요실금, 신장 결석과 같은 노화와 관련된 비뇨기과 질환이 보편화되고 있습니다. 이러한 질환은 노년층에서 많이 발생하며, 진단 및 치료용 비뇨기과 장비에 대한 수요가 증가하고 있습니다.
경제적인 측면에서 보면, 노인 인구 증가는 비뇨기과 수술 기기에 대한 투자를 포함한 의료비 지출의 붐을 주도하고 있습니다. 노인들은 더 자주 의료 서비스를 필요로 하므로 의료비 증가로 이어집니다. 이러한 인구 통계학적 변화로 인해 공공 및 민간 의료 부문은 비뇨기과 수술에 더 많은 자원을 투입하고 있으며, 그 결과 수술 장비 판매가 증가하고 있습니다. 또한 보다 진보된 저침습적 수술 기술에 대한 수요는 제조업체 시장 잠재력을 높이고 있습니다. 의료진은 고령 환자의 회복 기간을 단축하고 더 나은 결과를 얻기 위해 노력하고 있기 때문입니다.
기술적으로, 노인 인구 증가로 인해 노인 환자의 특수한 요구를 충족시키는 비뇨기과 수술 기기의 기술 혁신이 진행되고 있습니다. 최소 침습 수술, 로봇 보조 수술 및 첨단 영상 기술은 노인 환자의 수술 정확도를 높이고 문제를 줄이기 위해 사용되고 있습니다. 업계가 고령화 사회에 적응함에 따라 제조업체는 허약 및 동반 질환과 같은 고령 환자가 직면한 특정 문제를 해결하는 최첨단 제품 개발에 투자하고 있습니다. 이러한 기술 향상에 대한 열망은 환자의 결과를 개선하고 전체 비뇨기과 수술 기기 시장의 성장에 기여하고 있습니다.
수술 장비 비용의 상승은 비뇨기과 수술 장비 산업의 확장을 저해할 수 있습니다. 고급 비뇨기과 수술 장비의 비용 상승은 의료 서비스 프로바이더가 예산 제약에 직면하여 새로운 기술을 채택하는 능력을 제한할 수 있습니다. 이는 의료 예산이 제한된 지역이나 비용에 민감한 저소득층에게 특히 중요합니다. 이러한 가젯에 대한 지출이 증가하면 채택률이 감소하고 첨단 기기에 대한 접근성이 제한되어 전체 시장의 성장을 저해할 수 있습니다.
예를 들어 2024년 5월, 헬스케어 비용 연구소는 로봇 수술 시스템, 첨단 영상 장비 등 고급 비뇨기과 기술의 가격이 크게 상승했다고 보고했습니다. 보고서에 따르면 이러한 기술은 정확도와 치료 결과를 향상시키지만 높은 비용으로 인해 의료 시설, 특히 부유하지 않은 지역의 의료 시설에 재정적 압박을 가하고 있다고 합니다. 이러한 경제적 압박은 새로운 기술의 채택을 정체시키고 시장 성장에 부정적인 영향을 미칠 수 있습니다.
그러나 비용 증가의 영향을 상쇄하기 위한 노력이 진행 중인데, 2024년 6월 여러 주요 비뇨기과 기기 제조업체들이 독창적인 가격 전략과 의료 서비스 프로바이더와의 제휴를 통해 제품을 더 저렴하게 만들기 위한 시도를 발표했습니다. 이러한 노력에는 첨단 비뇨기과 기기 도입에 대한 경제적 장벽을 낮추기 위한 비용 부담 제도와 확장 가능한 기술 솔루션이 포함됩니다. 비용 상승은 여전히 문제이지만, 이러한 노력은 시장 성장의 균형을 맞추고 첨단 비뇨기과 수술 기술에 대한 접근성을 높이는 데 도움이 될 것으로 예상됩니다.
Urological problems include prostate cancer, kidney stones, and urine incontinence are becoming increasingly common. As these illnesses become more prevalent, there is a greater need for better diagnostic and surgical technology growth surpassing USD 39.47 Billion in 2024 and reachingUSD 57.39 Billion by 2031.
Furthermore, the trend to minimally invasive treatments and the incorporation of robotic-assisted technologies help to drive market expansion by improving surgical precision, shortening recuperation times, and improving patient outcomes. Technological breakthroughs, such as improvements in imaging and device materials, drive the market forward by providing more effective and less invasive treatment alternatives is expected to grow at aCAGR of about 4.79% from 2024 to 2031.
Urology Surgical Devices Market: Definition/ Overview
Urology surgical devices are specialized instruments and equipment used to diagnose, treat, and manage urological disorders involving the urinary tract and male reproductive system. These gadgets include instruments for minimally invasive surgery, robotic-assisted systems, and diagnostic imaging equipment. Urology surgical devices are used to treat a variety of conditions, including kidney stones, prostate cancer, urine incontinence, and bladder diseases. They make minimally invasive operations and traditional approaches more feasible, resulting in better patient outcomes and shorter recovery times. The future of urology surgical equipment seems promising, because to technological breakthroughs such as robotic surgery, improved imaging techniques, and smart devices for better diagnoses and treatment. Continued innovation strives to improve precision, reduce invasiveness, and increase patient comfort, hence broadening the applicability and effectiveness of these devices in treating complicated urological disorders.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
The growing elderly population is likely to boost the expansion of the urology surgical devices market. As the world's population ages, age-related urological disorders such benign prostatic hyperplasia (BPH), urine incontinence, and kidney stones become more common. These disorders are more common in older persons, which increases the demand for diagnostic and therapeutic urological devices.
From an economic aspect, the growing elderly population is driving a boom in healthcare spending, including investments in urology surgical instruments. Older persons frequently require medical attention, which leads to increased healthcare costs. This demographic transition causes both the public and commercial healthcare sectors to devote more resources to urological surgeries, resulting in higher sales of surgical instruments. Furthermore, the demand for more advanced and minimally invasive surgical technologies increases market potential for manufacturers, as healthcare practitioners strive to give better outcomes with shorter recovery periods for senior patients.
Technologically, the growing elderly population drives innovation in urology surgical instruments to satisfy the specific needs of older patients. Minimally invasive procedures, robotic-assisted operations, and advanced imaging technologies are being used to increase precision and reduce problems in elderly patients' surgeries. As the industry adjusts to suit the aging population, manufacturers invest in the creation of cutting-edge products that address specific issues that older patients confront, such as frailty and comorbidities. This desire for technological improvement improves patient outcomes and contributes to the overall growth of the urology surgical equipment market.
Rising surgical device costs may represent a hindrance to the expansion of the urology surgical devices industry. As the cost of sophisticated urology surgical instruments rises, healthcare providers may confront budget constraints that limit their capacity to adopt new technologies. This is especially important in regions with limited healthcare budgets or in low-income communities where cost sensitivity is strong. Increased spending on these gadgets may result in slower adoption rates and impede overall market growth by limiting access to cutting-edge equipment.
For instance, in May 2024, the Healthcare Cost Institute reported a considerable increase in the pricing of high-end urological technology, such as robotic surgical systems and advanced imaging instruments. According to the report, while these technologies improve precision and outcomes, their high costs put a financial pressure on healthcare facilities, particularly those in less affluent communities. This financial pressure may cause a sluggish adoption of new technology, thereby harming market growth.
However, initiatives are underway to offset the effects of increased expenses. In June 2024, several major urological device makers announced attempts to make their products more affordable through creative pricing strategies and collaborations with healthcare providers. These efforts include cost-sharing schemes and scalable technological solutions that aim to reduce the financial barrier to adopting sophisticated urological devices. While rising costs are still a problem, these initiatives are projected to help balance market growth and increase access to sophisticated urology surgical technology.
The increasing use of ureteroscopy is projected to drive the urology surgical devices market significantly. Ureteroscopy is a minimally invasive treatment that diagnoses and treats ureter and kidney diseases such as stones, tumors, and strictures. Its growing popularity is largely due to the procedure's success in treating these problems with shorter recovery times and fewer complications than traditional surgical treatments. As more patients and healthcare providers realize the benefits of ureteroscopy, its popularity grows, resulting in growing demand for specialized ureteroscopic instruments.
In May 2024, Olympus Corporation announced the launching of its next-generation flexible ureteroscope, which is expected to provide greater picture quality and agility. This innovative gadget intends to improve procedure outcomes and patient comfort, reflecting the growing desire for ureteroscopy in clinical practice. The launch of such novel equipment contributes to the increased demand for ureteroscopy and drives the growth of the urology surgical devices market.
Furthermore, healthcare institutions and legislative improvements have helped to boost the number of preventive and diagnostic urological treatments performed. For instance, in July 2024, the American Urological Association (AUA) issued guidelines advocating ureteroscopy for specific cases of kidney stones and ureteral obstruction. This endorsement from a renowned professional association promotes the use of ureteroscopy, boosting market growth by increasing the number of procedures performed and stimulating demand for better ureteroscopic technology.
Lithotripsy is the fastest-growing segment due to its non-invasive nature and effectiveness in removing kidney stones, which has increased in popularity. The expansion is aided by technical advancements that improve the precision and efficiency of lithotripsy procedures, catering to a larger patient population seeking less intrusive treatment options.
The increasing prevalence of Urolithiasis (kidney stones) is likely to cause considerable growth in the urology surgical device market. Kidney stones are a prevalent ailment that affects a big portion of the population, and their incidence is on the rise as a result of dietary changes, obesity, and dehydration. As the number of people diagnosed with kidney stones increases, so does the demand for efficient treatment alternatives, which drives the need for better urology surgical instruments.
Furthermore, the emphasis on early detection and preventative care is driving market growth. In July 2024, the American Urological Association (AUA) stressed the necessity of implementing improved diagnostic methods for early diagnosis of kidney stones, allowing for prompt and successful treatment. This endorsement leads to higher acceptance of urological devices designed for both diagnosis and treatment, which drives market growth as healthcare professionals engage in cutting-edge technologies to efficiently manage the growing incidence of urolithiasis.
Urinary incontinence is the fastest-growing area, thanks to increased awareness and advances in surgical procedures including implanted devices and neuromodulation therapies. The growing older population and improved diagnostic tools are driving strong growth in this category, as more patients seek effective urinary incontinence treatments.
Country/Region-wise
North America's strong acceptance rate of new technologies is projected to significantly drive the urological surgical devices market. North America, notably the United States and Canada, has a well-established healthcare infrastructure and a strong commitment to incorporating innovative technologies into clinical practice. The region's commitment to innovation and research results in rapid adoption of cutting-edge surgical equipment, boosting market growth by fulfilling the growing need for innovative and effective urological treatments.
In April 2024, the American Urological Association (AUA) published a report on the increasing usage of robotic-assisted surgical equipment for urological surgeries in North America. This survey noted a significant growth in the usage of these systems, which are driven by their capacity to provide more precision and better patient outcomes. The AUA's findings highlight the region's excitement for adopting new technology, which stimulates demand for innovative urology surgical instruments and propels market growth.
The growing awareness of urological problems in the Asia-Pacific region is likely to drive the urology surgical instruments market. As healthcare knowledge grows, more people seek diagnosis and treatment for urological problems, increasing the demand for improved surgical technologies. The increased emphasis on education and public health initiatives is helping to eliminate the stigma associated with certain disorders and promote early diagnosis, resulting in higher market growth.
For instance, in June 2024, the World Health Organization (WHO) announced a new program to raise awareness of urological health issues throughout the Asia-Pacific area. This campaign includes educational initiatives and screenings, which are expected to drive up demand for urological diagnostics and surgical technologies. The WHO's emphasis on improving access to care and early intervention is predicted to boost market growth by increasing the number of procedures performed and the use of new technology.
In July 2024, Medtronic also announced a strategic agreement with local health authorities in Asia-Pacific to increase the availability of its urological surgical equipment in emerging areas. This collaboration intends to meet the growing need for innovative surgical solutions in these regions, and it is projected to increase market penetration. This approach coincides with increased awareness and growing healthcare demands in the region by improving the availability of high-quality urological equipment and supporting local healthcare infrastructure, driving market expansion even further.
The competitive landscape of the urology surgical devices market is characterized by rapid technological advancements and a focus on innovation. Companies are continuously developing new devices with enhanced precision, minimally invasive techniques, and improved patient outcomes. The market sees a mix of large multinational corporations and specialized firms, all striving to differentiate themselves through product differentiation, strategic partnerships, and expanding their product portfolios to address a broad range of urological conditions. Additionally, increasing adoption of robotic-assisted surgeries and advancements in imaging technologies are shaping the competitive dynamics.
Some of the prominent players operating in the urology surgical devices market include:
Olympus
Boston Scientific
Medtronic
Teleflex
Karl Storz
Coloplast
Conmed
Stryker
Cook Medical
In May 2024, Boston Scientific purchased a urology device startup that offers new, minimally invasive therapies for urine incontinence. This acquisition will enable Boston Scientific to broaden its product offerings and incorporate cutting-edge technologies into its urology portfolio.
In July 2024, Fresenius Medical Care developed an improved dialysis device for urological applications, aimed at better patient treatment of chronic kidney disease. This device incorporates advanced filtration technology to help address urological issues caused by kidney disease.
In March 2024, Coloplast developed a novel urological catheter with enhanced materials and design characteristics to reduce infection rates and improve patient comfort. The catheter is intended to enhance the overall experience for patients who require long-term catheterization.